- Home
- ALDF vs CRVS Comparison
ALDF vs CRVS Comparison
Compare ALDF & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDF
- CRVS
- Stock Information
- Founded
- ALDF 2024
- CRVS 2014
- Country
- ALDF United States
- CRVS United States
- Employees
- ALDF N/A
- CRVS N/A
- Industry
- ALDF
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- ALDF
- CRVS Health Care
- Exchange
- ALDF NYSE
- CRVS Nasdaq
- Market Cap
- ALDF 299.9M
- CRVS 257.0M
- IPO Year
- ALDF 2024
- CRVS 2016
- Fundamental
- Price
- ALDF $10.11
- CRVS $3.21
- Analyst Decision
- ALDF
- CRVS Strong Buy
- Analyst Count
- ALDF 0
- CRVS 5
- Target Price
- ALDF N/A
- CRVS $12.63
- AVG Volume (30 Days)
- ALDF 30.1K
- CRVS 704.3K
- Earning Date
- ALDF 01-01-0001
- CRVS 05-05-2025
- Dividend Yield
- ALDF N/A
- CRVS N/A
- EPS Growth
- ALDF N/A
- CRVS N/A
- EPS
- ALDF N/A
- CRVS N/A
- Revenue
- ALDF N/A
- CRVS N/A
- Revenue This Year
- ALDF N/A
- CRVS N/A
- Revenue Next Year
- ALDF N/A
- CRVS N/A
- P/E Ratio
- ALDF $80.07
- CRVS N/A
- Revenue Growth
- ALDF N/A
- CRVS N/A
- 52 Week Low
- ALDF $9.98
- CRVS $1.30
- 52 Week High
- ALDF $11.46
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- ALDF N/A
- CRVS 29.29
- Support Level
- ALDF N/A
- CRVS $3.06
- Resistance Level
- ALDF N/A
- CRVS $3.45
- Average True Range (ATR)
- ALDF 0.00
- CRVS 0.37
- MACD
- ALDF 0.00
- CRVS -0.10
- Stochastic Oscillator
- ALDF 0.00
- CRVS 8.77
Stock Price Comparison Chart: ALDF vs CRVS
■ ALDF
■ CRVS
About ALDF ALDEL FINL II INC
Aldel Financial II Inc is a Shell Company with various businesses.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
Share on Social Networks:
0